RT Journal Article
SR Electronic
T1 First-line pharmacotherapy for tobacco use and dependence.
JF The Journal of the American Board of Family
                Practice
JO J Am Board Fam Med
FD American Board of Family Medicine
SP 489
OP 497
VO 15
IS 6
A1 Steve A Watts
A1 Sara L Noble
A1 Patrick O Smith
A1 Marilyn Disco
YR 2002
UL http://www.jabfm.org/content/15/6/489.abstract
AB First-line pharmacotherapies for tobacco use and dependence (namely, nicotine patch, nicotine gum, nicotine inhaler, nicotine nasal spray, and sustained-release bupropion) are safe and have been empirically determined to be efficacious and should always be considered part of a tobacco treatment intervention program unless contraindicated. Studies published subsequent to the literature synthesized in TTUD support previously determined efficacy of first-line pharmacologic medications for treatment of tobacco use and dependence. Further studies will be necessary to define clearly the efficacy and relative safety of combination treatments.